Showing results (351-360 of 4,122) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|March 27, 2001
CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in miceL Xu, T Daly, C Gao, et al.Human Gene Therapy|January 10, 2002
In vivo gene delivery via portal vein and bile duct to individual lobes of the rat liver using a polylysine-based nonviral DNA vector in combination with chloroquineX Zhang, L Collins, G J Sawyer, et al.Human Gene Therapy|November 21, 2000
Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapyN Kuriyama, H Kuriyama, C M Julin, et al.Human Gene Therapy|November 21, 2000
Virus-mediated gene transfer for cutaneous gene therapyS Ghazizadeh, L B TaichmanHuman Gene Therapy|November 21, 2000
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosaE Dellambra, G Pellegrini, L Guerra, et al.Human Gene Therapy|December 19, 2000
Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoterV Braiden, A Ohtsuru, Y Kawashita, et al.Human Gene Therapy|December 19, 2000
Preincubation with endothelial cell monolayers increases gene transfer efficiency into human bone marrow CD34(+)CD38(-) progenitor cellsJ P Chute, A Saini, M Wells, et al.Human Gene Therapy|November 24, 1999
A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptideA Jiang, H Fisher, R J Pomerantz, et al.Human Gene Therapy|November 24, 1999
Insulin delivery with plasmid DNAA M Abai, P M Hobart, K M BarnhartHuman Gene Therapy|November 24, 1999
Prophylaxis of antibody-induced acute glomerulonephritis with genetically modified bone marrow-derived vehicle cellsT Yokoo, T Ohashi, Y Utsunomiya, et al.Pageof 413